TNF and obstructive sleep apnea syndrome: This is in line with previous clinical trials showing improvements in TNF-a after healthy lifestyle interventions in individuals of increased cardiometabolic risk (e.g., those with metabolic syndrome) and patients with diabetes mellitus type 2 and cardiovascular disease, conditions which are tightly linked to OSA from a pathophysiological point of view [20,21].